Patient's own infection-fighting T cells put late-stage melanoma into long-term remission
Thursday, June 19, 2008 - 06:21
in Health & Medicine
Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumour cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Centre, reports these findings in the 19 June issue of the New England Journal of Medicine...
Read the whole article on Science Centric
More from Science Centric
Related
- Patient's own infection-fighting T cells put late-stage melanoma into long-term remissionWed, 18 Jun 2008, 20:29:24 EDT
- Study shows cancer vaccines led to long-term survival for patients with metastatic melanomaTue, 28 Jul 2009, 13:55:44 EDT
- Long-term treatment with proton pump inhibitor can increase weightFri, 23 Oct 2009, 13:50:47 EDT
- Markers for inflammation discovered in breast cancer survivors are linked to survivalTue, 26 May 2009, 16:37:54 EDT
- Risk assessment plays key role in long-term treatment of breast cancerTue, 12 Aug 2008, 15:42:59 EDT